These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29499951)

  • 1. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.
    Esposito CL; Nuzzo S; Catuogno S; Romano S; de Nigris F; de Franciscis V
    Mol Ther Nucleic Acids; 2018 Mar; 10():398-411. PubMed ID: 29499951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3.
    Esposito CL; Nuzzo S; Ibba ML; Ricci-Vitiani L; Pallini R; Condorelli G; Catuogno S; de Franciscis V
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gint4.T-siHDGF chimera-capped mesoporous silica nanoparticles encapsulating temozolomide for synergistic glioblastoma therapy.
    Fei H; Jin Y; Jiang N; Zhou Y; Wei N; Liu Y; Miao J; Zhang L; Li R; Zhang A; Du S
    Biomaterials; 2024 Apr; 306():122479. PubMed ID: 38295649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts.
    Ibba ML; Ciccone G; Rotoli D; Coppola G; Fiorelli A; Catuogno S; Esposito CL
    Mol Ther Nucleic Acids; 2023 Jun; 32():111-126. PubMed ID: 37020682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma.
    Yoon S; Wu X; Armstrong B; Habib N; Rossi JJ
    Mol Ther Nucleic Acids; 2019 Mar; 14():131-141. PubMed ID: 30594071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.
    Camorani S; Esposito CL; Rienzo A; Catuogno S; Iaboni M; Condorelli G; de Franciscis V; Cerchia L
    Mol Ther; 2014 Apr; 22(4):828-41. PubMed ID: 24566984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo.
    Cen B; Wei Y; Huang W; Teng M; He S; Li J; Wang W; He G; Bai X; Liu X; Yuan Y; Pan X; Ji A
    Mol Ther Nucleic Acids; 2018 Dec; 13():220-232. PubMed ID: 30312846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model.
    Linder B; Weirauch U; Ewe A; Uhmann A; Seifert V; Mittelbronn M; Harter PN; Aigner A; Kögel D
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30857197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
    Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
    Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Vilardo C; Nuzzo S; Ricci-Vitiani L; De Luca G; Pallini R; Kichkailo AS; Lapin IN; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2019 Dec; 18():99-109. PubMed ID: 31541799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4'-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells.
    Cheng YP; Li S; Chuang WL; Li CH; Chen GJ; Chang CC; Or CR; Lin PY; Chang CC
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
    Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
    Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier.
    Shi S; Fu W; Lin S; Tian T; Li S; Shao X; Zhang Y; Zhang T; Tang Z; Zhou Y; Lin Y; Cai X
    Nanomedicine; 2019 Oct; 21():102061. PubMed ID: 31344499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
    Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
    Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.